在功能性消化不良中减少胃粘膜神经密度:临床意义和功能相关性
Yao-Chun Yang1, Ping-Huei Tseng2, Chieh-Chang Chen2
1School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
The American journal of gastroenterology
|January 6, 2025
概括
在功能性消化不良 (FD) 患者中,胃粘膜神经密度 (GMND) 降低,与症状严重程度相反相关. 这一发现突出了FD病变发生的潜在神经学因素.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 病理生理学 病理生理学
背景情况:
- 功能性消化不良 (FD) 是一种常见的胃肠道疾病,具有复杂的病理生理学.
- 胃粘膜神经密度 (GMND) 是胃肠道疾病的潜在生物标志物.
研究的目的:
- 在FD患者中定量评估GMND.
- 研究GMND与FD症状和胃功能的临床相关性.
主要方法:
- 一项前性研究,比较了35名FD患者和16名健康对照.
- 通过内镜活检评估的GMND.
- 使用了胃排空扫描和胃衰竭枢纽症状指数 (GCSI) 的得分.
主要成果:
- 与对照人群相比,FD患者在胃,身体和胃底部表现出明显较低的GMND.
- GMND与GCSI得分有显著的反相关性,表明神经密度较低的症状更严重.
- 没有发现GMND和胃空化扫描参数之间的显著相关性.
结论:
- 在功能性消化不良的患者中,GMND的降低.
- 减少的GMND与FD症状严重程度的增加有关.
- 这些发现表明,改变胃内膜在FD病理生理学中的作用.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
537
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
537
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
88
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
88
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
353
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
353
Peptic Ulcer Disease I: Introduction
131
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
131
Gastritis-II: Pathophysiology
233
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
233
Gastritis III: Clinical Manifestations and Management
150
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
150


